Real-World Data of Trastuzumab Deruxtecan for Advanced Gastric Cancer: A Multi-Institutional Retrospective Study

Real-World Data of Trastuzumab Deruxtecan for Advanced Gastric Cancer: A Multi-Institutional Retrospective Study

Trastuzumab deruxtecan (T-DXd) has shown promising efficacy against <i>HER2-</i>positive advanced gastric cancer (AGC). However, data on its real-world efficacy in AGC patients are insufficient, and the predictive marker of T-DXd is unclear. In this multi-center retrospective study, we c...

Full description

Bibliographic Details
Main Authors: Toshihiko Matsumoto, Shogo Yamamura, Tatsuki Ikoma, Yusuke Kurioka, Keitaro Doi, Shogen Boku, Nobuhiro Shibata, Hiroki Nagai, Takanobu Shimada, Takao Tsuduki, Takehiko Tsumura, Masahiro Takatani, Hisateru Yasui, Hironaga Satake
Format: Article
Language:English
Published: MDPI AG 2022-04-01
Series:Journal of Clinical Medicine
Subjects:
gastric cancer
trastuzumab deruxtecan
T-DXd
chemotherapy
real-world data
Online Access:https://www.mdpi.com/2077-0383/11/8/2247

Internet

https://www.mdpi.com/2077-0383/11/8/2247

Similar Items